>this PR is to my knowledge the first time Merrimack has publicly disclosed a timetable for the uveitis trial: results are expected in 2008.< I like, I like -
As posted on May 23 -
>When mentioned facetiously a possible GTC-Merrimack merger - contact stated - "You never know. You never know."<
Merrimack is still a private company with an impressive potential and a good deal of cash. GTCB is publicly traded with an impressive potential but in need of cash. A merger of the two would make a lot of sense for Merrimack as they will secure their future supplies and their stock becomes instantly listed and traded; it would also make a lot of sense for GTCB who is in dire need of a white night rescue...
What do you guys think? Is this the reason that Merrimack just secured another $60 Million? If that is the case, should we not expect to easily pass $1 after such a merger???